Correlation Between Decibel Therapeutics and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Decibel Therapeutics and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Decibel Therapeutics and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Decibel Therapeutics and Eliem Therapeutics, you can compare the effects of market volatilities on Decibel Therapeutics and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Decibel Therapeutics with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Decibel Therapeutics and Eliem Therapeutics.
Diversification Opportunities for Decibel Therapeutics and Eliem Therapeutics
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Decibel and Eliem is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Decibel Therapeutics and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Decibel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Decibel Therapeutics are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Decibel Therapeutics i.e., Decibel Therapeutics and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Decibel Therapeutics and Eliem Therapeutics
Given the investment horizon of 90 days Decibel Therapeutics is expected to under-perform the Eliem Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Decibel Therapeutics is 1.58 times less risky than Eliem Therapeutics. The stock trades about -0.24 of its potential returns per unit of risk. The Eliem Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 298.00 in Eliem Therapeutics on August 31, 2024 and sell it today you would earn a total of 6.00 from holding Eliem Therapeutics or generate 2.01% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 8.6% |
| Values | Daily Returns |
Decibel Therapeutics vs. Eliem Therapeutics
Performance |
| Timeline |
| Decibel Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Eliem Therapeutics |
Decibel Therapeutics and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Decibel Therapeutics and Eliem Therapeutics
The main advantage of trading using opposite Decibel Therapeutics and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Decibel Therapeutics position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Decibel Therapeutics vs. Werewolf Therapeutics | Decibel Therapeutics vs. Edgewise Therapeutics | Decibel Therapeutics vs. Celcuity LLC | Decibel Therapeutics vs. C4 Therapeutics |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |